OTC Mouthpiece for Snoring

Zyppah

Status and phase

Completed

Phase 3

Conditions

Snoring

Treatments

Device: Zyppah Anti-snoring Appliance

Study type

Interventional

Funder types

Industry

Identifiers

NCT03128307

Zyppah01

Details and patient eligibility

About

Online patient registration to participate in clinical trial to test OTC mouthpiece that controls position of the tongue to reduce snoring.

Full description

Patient will complete informed consent, inclusion/exclusion criteria, sleep apnea and snoring surveys online. If patient meets all criteria for the study, patient will be provided with a treatment device for use for a 10 day treatment period. Patient will complete the trial upon providing final online surveys.

Enrollment

604 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Over 18 years of age
Living in the United States
Signing the Informed Consent Form

Exclusion criteria

Missing teeth (as the device won't be properly fitted)
Any severe breathing or respiratory disorder, such as chronic asthma, emphysema, COPD, or a similar condition
Poor dental health, such as severe gum disease, loose teeth, an abscess, mouth sores, or bleeding gums
A dental implant placed within the last three months
Diagnosed with a Temporomandibular joint condition (TMJ)
Actively experiencing any mouth or jaw pain, including clenching of the teeth, grinding, or any other physical injury to the jaw or teeth
Full dentures
Braces
Diagnosis of sleep apnea
Less than 18 years of age